Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Iron Poisoning, Emergency Medicine


Basics


Description


  • Peak concentrations are 2-4 hr postingestion
  • Serum concentrations not reliable if obtained >4-6 hr after ingestion:
    • Enteric coated or sustained release-warrants serial levels
  • Postabsorption: Iron redistributes into tissues, and fall in serum iron occurs as free iron shifts intracellularly resulting in cellular injury
  • Injury patterns:
    • Corrosive injury to intestinal mucosa may result in profound fluid loss (shock), hemorrhage, and perforation
    • Liver receives largest load of iron because of portal venous circulation-(hemorrhagic periportal necrosis)
  • Free iron:
    • Concentrates in mitochondria, disrupting oxidative phosphorylation; catalyzes lipid peroxidation and free radical formation, resulting in cell death; increases anaerobic metabolism and acidosis
    • Causes myocardial depression, venodilation, and cerebral edema
  • Hydration of ferric form liberates 3 protons, resulting in acidemia

Etiology


Elemental iron ingestion:  
  • Nontoxic <20 mg/kg
  • Moderate to severe >40 mg/kg
  • Lethality possible >60 mg/kg
  • Elemental iron equivalents:
    • Ferrous sulfate, 20% (325 mg = 65 mg Fe)
    • Ferrous gluconate, 12%
    • Ferrous fumarate, 33%
  • Prenatal vitamins vary from 60-90 mg elemental iron per tablet
  • Childrens vitamins may contain 5-18 mg elemental iron per tablet

  • Historically notorious for the highest mortality rate among pediatric accidental exposures (adult iron products)
  • Children's chewable iron products have been shown to be safe

Diagnosis


Signs and Symptoms


  • Classically divided into 5 stages:
    • Stage 1: GI (0.5-6 hr):
      • Abdominal pain
      • Vomiting
      • Diarrhea
      • Hematemesis
      • Hematochezia
    • Stage 2: Latent/quiescent (6-24 hr):
      • Resolution of GI symptoms
      • Deceptive phase (ongoing injury?)
      • Possible hypotension and acidosis
    • Stage 3: Shock and organ failure (6-72 hr):
      • Hypoperfusion
      • Metabolic acidosis
      • Coma
      • Coagulopathy
    • Stage 4: Hepatic failure (2-3 days):
      • Coagulopathy
      • Hypoglycemia
      • Jaundice
      • Elevated LFTs (transaminases) and bilirubin
    • Stage 5: Obstruction (2-4 wk):
      • Gastric outlet and small bowel obstruction
      • Abdominal pain, vomiting
  • Patient may present in or skip any of the 5 stages
  • If onset of stage 1 does not occur within 6 hr, likely not significant ingestion

Essential Workup


Acute iron poisoning is a clinical diagnosis, regardless of lab results  

Diagnosis Tests & Interpretation


Lab
  • Serum iron levels (mg/dL):
    • Peak absorption 2-6 hr
    • 4 hr is most common time for peak
    • Delayed peak with enteric coated/sustained release
  • Electrolytes, BUN/creatinine, glucose:
    • Anion gap metabolic acidosis
    • Hyperglycemia early
    • Hypoglycemia late
  • Arterial blood gas:
    • Metabolic acidosis
  • CBC:
    • Anemia with significant hemorrhage
    • Leukocytosis
  • Liver function
  • Coagulation profile
  • Lactate
  • Type and screen if hemorrhage
  • Total iron-binding capacity is not useful and not recommended

Imaging
Abdominal radiograph check for:  
  • Tablets (childrens chewables rarely visible)
  • Absence of pill fragment interpretation:
    • Patient did not ingest iron
    • Iron was in solution or has already dissolved
    • Patient ingested pediatric multivitamin product
    • Absence of radiopacities does not rule out significant or lethal ingestion
  • Perforation

Differential Diagnosis


  • Sepsis
  • Acetaminophen toxicity
  • Toxic ingestions causing anion gap acidosis:
    • Salicylate
    • Cyanide
    • Methanol
    • Ethylene glycol
  • Mushrooms
  • Heavy metals
  • Theophylline toxicity
  • GI bleed from other causes (alcoholic liver disease)

Treatment


Pre-Hospital


Collect prescription bottles/medications for identification in the ED  

Initial Stabilization/Therapy


  • ABCs:
    • Intubate if profoundly unstable
    • Venous access and fluids for hypotension
    • Cardiac monitor and pulse oximetry
  • Naloxone, thiamine, dextrose (or Accu-Chek) as indicated for altered mental status

Ed Treatment/Procedures


  • Decontamination:
    • Poorly adsorbed by activated charcoal
    • Gastric lavage has not been shown to change outcome
    • NaHCO3, phospho soda, and oral deferoxamine are not recommended
    • If pill fragments are visualized on x-ray, or history of significant ingestion:
      • Consider whole bowel irrigation (with NG GoLytely: Peds: 10-15 mL/kg/h; adult: 1-2 L/h) while monitoring progression with radiograph (KUB).
      • Caution with GI bleed
    • Endoscopy or gastrotomy can remove bezoar formation after massive ingestions (>240 mg/kg)
  • Chelation with deferoxamine (DFO):
    • DFO is a highly specific chelator of parenteral iron
    • IV infusion results in more constant DFO levels and is route of choice:
      • Administer as soon as possible (<24 hr)
    • Administration techniques:
      • Increase IV infusion rate to 15 mg/kg/h over 20 min, monitoring for hypotension
      • Decrease infusion rate if hypotension
      • Infusion rates as high as 45 mg/kg/h have been tolerated
      • Disregard manufacturers recommendation of max. daily doses of 6 g in serious iron exposures
    • IM DFO challenge test is not advocated
    • Interpret serum levels cautiously:
      • Time since ingestion must be considered: Treatment may be indicated in patient who presents late, after distribution stage (>8 hr postingestion), with serum iron level <350 mg/dL
    • If serum iron levels are not readily available, base treatment decisions on clinical status
    • Length of infusion (controversial):
      • DFO-iron complex causes urine to turn vin rose color; this suggests continuing infusion until urine returns to normal
      • Resolution of signs and symptoms of significant toxicity is criterion for discontinuing DFO
      • Prolonged DFO therapy >24-48 hr may precipitate adult respiratory distress syndrome
      • In severe cases with continued signs and symptoms, infusion may be continued cautiously at lower dose
    • Controversies:
      • Safety of DFO infusions given for >24 hr
      • Maximal infusion rates and total amount
      • Serum iron concentration warranting treatment
      • Endpoint of treatment (best endpoint is resolution of poisoning, i.e., acidemia)
      • Role of extracorporeal elimination
    • Contact regional poison center for moderate to severe iron exposures
      • (1-800-222-1222)

Medication


  • Dextrose: D50W 1 amp (50 mL or 25 g; peds: D25W 2-4 mL/kg) IV
  • Naloxone (Narcan): 2 mg (peds: 0.1 mg/kg) IV or IM initial dose
  • Thiamine (vitamin B1): 100 mg (peds: 50 mg) IV or IM

Follow-Up


Disposition


Admission Criteria
  • GI symptoms or dehydration
  • Altered mental status
  • Hypotension, lethargy, metabolic acidosis, or shock
  • Serum iron >500 mg/dL
  • Serum iron >350 mg/dL and pills seen on KUB
  • Rising serum iron levels
  • Patients treated with deferoxamine
  • ICU admission for coma, shock, metabolic acidosis, or iron levels >1,000 mg/dL

Discharge Criteria
  • Asymptomatic with negative radiograph
  • Minimal to no symptoms after 6-hr observation
  • Mild GI symptoms that have resolved without evidence of metabolic acidosis and serum iron <350 mg/dL

Issues for Referral
Contact regional poison center for mild to moderate toxicity  

Follow-Up Recommendations


  • Follow-up after discharge may be indicated in patients who are at risk of developing gastric outlet obstruction
  • Psychiatric referral for patients with intentional overdose

Pearls and Pitfalls


  • DFO may be indicated in patients who present late, after distribution stage (>8 hr postingestion), or with serum iron level <350 mg/dL and signs of intracellular poisoning (e.g., anion gap metabolic acidosis)
  • Resolution of GI symptoms does not indicate that there is no ongoing toxicity that may progress over time

Additional Reading


  • Bryant  SM, Leikin  J. Iron. In: Brent  J, Wallace  KL, Burkhart  KK, et al., eds. Critical Care Toxicology. St. Louis, MO: Mosby; 2005.
  • Chang  TP, Rangan  C. Iron poisoning: A literature-based review of epidemiology, diagnosis, and management. Pediatr Emerg Care.  2011;27:978-985.
  • Tenenbein  M. Unit-dose packaging of iron supplements and reduction of iron poisoning in young children. Arch Pediatr Adolesc Med.  2005;159:557-560.

Codes


ICD9


964.0 Poisoning by iron and its compounds  

ICD10


  • T45.4X1A Poisoning by iron and its compounds, accidental, init
  • T45.4X4A Poisoning by iron and its compounds, undetermined, init

SNOMED


  • 445902007 Poisoning by iron (disorder)
  • 216802005 Accidental poisoning by iron compounds (disorder)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer